Research from a team at Mount Sinai provides reassurance that a SARS-CoV-2 infection in early pregnancy that has resolved by the time of delivery does not appear to adversely affect maternal or fetal outcomes.
Some prior studies have shown increased risks for adverse pregnancy outcomes among women who had SARS-CoV-2 infection during pregnancy, but these were based on testing that was performed due to acute symptoms or routine screening at delivery. In the current study, which included women with asymptomatic prior infection earlier in pregnancy, no increased risks for outcomes such as preterm birth or neonatal abnormalities were found. The results were published in November 2021 in Paediatric and Perinatal Epidemiology.
